Sun, Mar 10, 2024
Sun Pharmaceutical Industries Inc is recalling 47,520 bottles (40mg) and 7,488 bottles (80 mg) respectively of the medication due to Current Good Manufacturing Practice regulations (CGMP) deviations, it stated.
More >
Wed, Jan 31, 2024
Sun Pharma Q3 Results: Sun Pharmaceutical Industries Ltd on Wednesday reported a 16.52 per cent rise in its consolidated net profit to Rs 2,523.8 crore in the third quarter ended December 31, 2023.
Tue, Jan 30, 2024
Sun Pharma Q3 Preview: Margins are estimated to remain flat at 26.5 per cent against 26.7 per cent registered in Q3 FY23.
Mon, Jun 06, 2022
Drug major Sun Pharma plans to increase its field force in the domestic market by 10 per cent in the current fiscal in order to drive twin objectives of brand focus and geographical expansion, according to a senior company official.
Tue, May 31, 2022
Indian markets on Tuesday witnessed a gap-down opening as Sensex slumped over 300 points and Nifty above 16600 levels. Almost all indices were in red with Nifty IT and FMCG being the top losers.
Sun, May 22, 2022
The drug is used to treat depression and prevent Seasonal Affective Disorder (SAD). It is also used to help people stop smoking.
Thu, Mar 31, 2022
The National Pharma Pricing Authority (NPPA) has approved 10.8% hike in over 800 essential drugs starting April 1,2022. This is the biggest hike by NPPA in the last 10 years.
Tue, Mar 22, 2022
Sun Pharma on Monday said it has entered into a share purchase agreement with Japan's Daiichi Sankyo Company to acquire the latter's 11.28 percent stake in Zenotech Laboratories.
Mon, Feb 07, 2022
Sun Pharma rose over 40 percent in the last 1 year compared to 17 per cent upside seen in the Nifty50 in the same period and the rally is not over yet, suggest experts.
Wed, Feb 02, 2022
According to the press statement of Sun Pharma, the board of directors has fixed Thursday, February 10, 2022, as the record date to determine the names of the equity shareholders, who shall be entitled to receive payment towards interim dividend of the Company for the current fiscal.”
Tue, Feb 01, 2022
We have collated a list of recommendations from various global brokerage firms according to a Zee Business TV report.
Mon, Jan 31, 2022
While the margins of the company contracted by 60 basis points to 26.4 per cent in the third quarter of FY22 from 27 per cent in a year ago quarter.
Mon, Jan 17, 2022
The Indian markets could consolidate on Monday tracking muted global cues but there will be a stock-specific action in which global brokerages tweaked their rating or specific reports.
Fri, Dec 31, 2021
The benchmark indices have given over 20 per cent return in one year so far. The buying interest was broadly seen from all sectors.
Wed, Dec 29, 2021
The rise of the Covid-19 variant Omicron has once again brought pharma shares in focus.
Thu, Dec 23, 2021
Organisation of Pharmaceutical Producers of India (OPPI) Director-General K G Ananthakrishnan told PTI that it is crucial for the industry to further build momentum towards the gains secured over the course of the pandemic which will help it carve a niche in the global pharma value chain.
Wed, Nov 03, 2021
Global brokerage firms such as CLSA, Jefferies, Macquarie raised their target price on Sun Pharma post September quarter results.
Tue, Nov 02, 2021
Pharma giant Sun Pharmaceutical Industries on Tuesday reported 13 per cent rise in Profit After Tax (PAT), beating expectation of the street.
Thu, Oct 28, 2021
Homegrown pharma major Sun Pharmaceutical Industries Ltd on Thursday said it has launched its medicine ILUMYA used in the treatment of adults with moderate-to-severe plaque psoriasis in Canada.
Wed, Oct 27, 2021
In the 20-share index, 17 advanced while 3 declined. The 52-week high is 14,938.25. The biggest gainers were Divi’s Laboratories Limited followed by Sun Pharmaceuticals Industries Limited and Strides Pharma Limited which were up almost 2.9, 2.1 and 2.1 per cent respectively
Fri, Sep 10, 2021
On the eve of Ganesh Chaturthi, Market Experts and Analysts have suggested 6 vignaharta shares which can give huge profits and good returns to the investors in a period of one year.
Fri, Jul 30, 2021
The pharmaceutical major — Sun Pharma on Friday reported in-line first-quarter results, as expected by the majority of the brokerages, it posted a net profit of Rs 1,444.17 crore for the June-ended quarter of the financial year 2021-22, as compared to a net loss of Rs 1,655.6 crore in the same period last year.
Fri, May 28, 2021
Amid profit booking and lower-than-expected quarter-four estimates, Sun Pharma declined around four per cent to Rs 673 per share at around 2:30 pm on the BSE intraday trade on Friday. The stock is the top laggard in the Nifty Pharma index, which is declined most than its sectoral peers.
By accepting cookies, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts.